---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-106571"
form_type: "8-K"
ticker: "KODK"
cik: "0000031235"
company_name: "EASTMAN KODAK CO"
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:51:34.738906+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Kodak Q2 net loss $26M; going concern doubt raised on debt obligations

## Summary
- GAAP net loss of $26M vs net income of $26M in Q2 2024; revenue $263M, down 1% YoY.
- Operational EBITDA $9M, down 25% YoY; lower volumes and higher aluminum and manufacturing costs.
- Substantial doubt about going concern due to debt and preferred stock; pension reversion plan not solely within control.
- AM&C pharma facility FDA-registered; will start PBS production, bridge to injectable IV saline.
- Cash $155M, down $46M from Dec 31, 2024; Q2 cash use improved to $3M reduction.

## SEC filing metadata
- accession: 0000950170-25-106571
- form_type: 8-K
- ticker: KODK
- cik: 0000031235
- company_name: EASTMAN KODAK CO
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/31235/000095017025106571/0000950170-25-106571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/31235/000095017025106571/kodk-20250811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-106571
- JSON: https://secwatch.observer/filing/0000950170-25-106571.json
- Plain text: https://secwatch.observer/filing/0000950170-25-106571.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.